Publisert 25.11.2020

Regenics presents at Marine Biotechnology Conference 2020 Sweden

 

  This one-day conference and meeting point addresses the ongoing rapid development in marine biotechnology. The programme will be divided into two sessions - Marine Materials (before lunch) and Antifouling (after lunch). This is the second meeting in what is planned to be a series of annual meetings on marine biotechnology in the region, with the goal to provide a connection hub for academia and industry. The last meeting was well attended with over 100 participants. We hope for similar good response this year. Here is a link to the 2019 conference, Marine Biotechnology - Marine Products for Health >>

  Sponsored by: 

Regenics presenter Nov 25th 2020 CEO Henrik Lund. 

2020 Full Meeting program

  

Funding for the coordinator Regenics AS is provided  by the Research Council of Norway, while FORMAS (Swe) and Innovationsfonden (Dk) are the funding bodies of the Swedish and Danish partners, RISE Institute (Swe) and Charles Rivers Lab (US, Dk).

      

 

Regenics AS have developed clinical proof of efficacy and safety  in human 2 degree burn wounds for our products Collex® and Vernex®.

The procudts are beeing developed as class III devices. WoundClear® is developed as a BLA/EU CP biotech drug.